Ligand Enters Global License Agreement with CURx Pharmaceuticals, Inc. for Captisol-EnabledTM Topiramate Injection August 14, 2013
Ligand Partner GlaxoSmithKline Receives Positive CHMP Opinion for REVOLADE™ in Thrombocytopenia Associated with Chronic Hepatitis C Infection July 26, 2013
Ligand Announces Positive Preclinical Data for Glucagon Program in Model of Type 1 Diabetes June 24, 2013